RENE
RODRIGUEZ GONZALEZ
Instituto de Salud Carlos III
Madrid, EspañaPublications in collaboration with researchers from Instituto de Salud Carlos III (13)
2023
-
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
Nature Communications, Vol. 14, Núm. 1
-
Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways
Biomedicine and Pharmacotherapy, Vol. 161
2021
-
Cancer stem cells and clonal evolution in bone sarcomas
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside (Elsevier), pp. 371-391
2020
-
Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL
Blood, Vol. 136, Núm. 3, pp. 313-327
-
Sarcoma treatment in the era of molecular medicine
EMBO Molecular Medicine, Vol. 12, Núm. 11
-
Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications
Cancers, Vol. 12, Núm. 4
2019
2018
-
Role of Activator Protein-1 Complex on the Phenotype of Human Osteosarcomas Generated from Mesenchymal Stem Cells
Stem Cells, Vol. 36, Núm. 10, pp. 1487-1500
2016
-
Aldh1 Expression and Activity Increase during Tumor Evolution in Sarcoma Cancer Stem Cell Populations
Scientific Reports, Vol. 6
-
Osteosarcoma: Cells-of-Origin, Cancer stem cells, and targeted therapies
Stem Cells International, Vol. 2016
2015
-
Bone microenvironment signals in osteosarcoma development
Cellular and Molecular Life Sciences, Vol. 72, Núm. 16, pp. 3097-3113
2014
-
Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells
Stem Cells, Vol. 32, Núm. 5, pp. 1136-1148
2011
-
FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells
Stem Cells, Vol. 29, Núm. 2, pp. 179-192